Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

DHEA boosts bone cell growth and differentiation in elderly stem cells.

Enhanced stem cells from the placenta can help treat Graves' eye disease by stopping fat cell growth.

A woman with non-classic CAH had unusual heavy periods and high hormone levels, improved with treatment.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

Hormone replacement therapy improves skin health and reduces aging signs in postmenopausal women.

The testes control steroid production through complex interactions involving various cells and signaling molecules.

Genetic response to androgens is key in female pattern baldness, not SHBG levels.

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

The method can measure multiple hormones in women's hair and may help identify hormone-related health issues.

The patient likely has Chrousos syndrome, a rare condition causing insensitivity to glucocorticoids, requiring high-dose dexamethasone treatment.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Hormones like testosterone affect skin functions and can cause skin issues when in excess; treatments to manage these effects are only somewhat effective.

A rare ovarian tumor caused high testosterone and excess hair in a woman, which was resolved after tumor removal.

The document explains how to make a compound called 3.BETA.-Benzoyloxy-4-pregnen-16.ALPHA.,17.ALPHA.-epoxy-6,20-dione and describes its crystal structure.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

A rare adrenal gland tumor can cause unusual symptoms due to hormone changes.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Men might have a version of the female disease, polycystic ovarian syndrome, shown by changes in hormone levels and early baldness, but more research is needed to fully understand it.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.